# US 2026/0193169 A1 · Methods for preparing beta-alanine, beta-alanine salt and pantothenate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0193169 A1
- Document ID: US20260193169A1
- Status: Published application
- Kind: A1
- Application number: 19/529,055
- Filed: 2026-02-03
- Published: 2026-07-09
- Earliest claimed: 2019-03-20
- Assignees: Guang An Mojia Biotechnology Co., Ltd.
- Applicants: Guang An Mojia Biotechnology Co., Ltd.
- Inventors: Man Kit LAU; Yan CHEN; Ansen CHIEW; Chengliang LU; Congming ZENG; Jinhuan SU; Weihua LU
- Web page: https://patentgrep.com/patent/US20260193169A1

## CPC

- C07C 235/12: having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C 227/06: by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C 227/08: by reaction of ammonia or amines with acids containing functional groups
- C07C 227/18: by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C 231/02: from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
- C12N 9/88: Lyases (4.)
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12P 13/02: Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}
- C12P 13/06: Alanine; Leucine; Isoleucine; Serine; Homoserine
- C12Y 401/01011: Aspartate 1-decarboxylase (4.1.1.11)
- C12Y 403/01001: Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
- C07B 2200/07: Optical isomers
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Provided is a method for preparing β-alanine, the method comprising: preparing a β-alanine product from a reactant containing fumaric acid and aqueous ammonia in the presence of a catalyst, wherein the catalyst contains a catalyst composition containing aspartase and L-aspartic acid-α-decarboxylase, and adding fumaric acid during the reaction, wherein the total moles of the fumaric acid added is equal to the initial moles of the aqueous ammonia in the reactant minus the initial moles of the fumaric acid in the reactant. Also provided are methods for preparing a β-alanine salt (in particular calcium β-alanine, sodium β-alanine, and potassium β-alanine) and a pantothenate (in particular calcium pantothenate, sodium pantothenate, and potassium pantothenate).

## Claims

### Claim 1

A method for preparing β-alanine, comprising:
preparing a β-alanine product from a reactant containing fumaric acid and aqueous ammonia in the presence of a catalyst,
wherein the catalyst comprises a catalytic composition containing an aspartase and an L-aspartate-α-decarboxylase, and
adding fumaric acid during reaction, wherein total mole of the fumaric acid added is equal to an initial mole of the aqueous ammonia in the reactant minus an initial mole of the fumaric acid in the reactant;
wherein the aspartase is derived from Anoxybacillus flavithermus; and the L-aspartate-α-decarboxylase is derived from Bacillus thermotolerans,
wherein the aspartase derived from Anoxybacillus flavithermus has an amino acid sequence encoded by the sequence set forth in SEQ ID NO: 1;
wherein the L-aspartate-α-decarboxylase derived from Bacillus thermotolerans has an amino acid sequence encoded by the sequence set forth in SEQ ID NO: 3; and
wherein the reaction is terminated when the molar conversion rate of aspartic acid is more than 99%.

### Claim 2 (depends on 1)

The preparation method according to claim 1, wherein the catalytic composition contains a purified aspartase and a purified L-aspartate-α-decarboxylase.

### Claim 3 (depends on 1)

The preparation method according to claim 1, wherein the catalytic composition contains bacteria expressing aspartase and L-aspartate-α-decarboxylase.

### Claim 4 (depends on 3)

The preparation method according to claim 3, wherein the bacteria comprise wet bacteria, immobilized bacteria, or disrupted liquid of bacteria.

### Claim 5 (depends on 3)

The preparation method according to claim 3, wherein the bacteria are derived from recombinantly engineered bacteria.

### Claim 6 (depends on 3)

The preparation method according to claim 3, wherein the bacteria comprise bacteria expressing aspartase alone and bacteria expressing L-aspartate-α-decarboxylase alone.

### Claim 7 (depends on 6)

The preparation method according to claim 6, wherein a weight percentage of the bacteria expressing aspartase alone to the initial fumaric acid in the reactant is 0.5%-4% (w/w); and a weight percentage of the bacteria expressing L-aspartate-α-decarboxylase alone to the initial fumaric acid in the reactant is 10%-30% (w/w).

### Claim 8 (depends on 3)

The preparation method according to claim 3, wherein the bacteria comprise bacteria co-expressing aspartase and L-aspartate-α-decarboxylase.

### Claim 9 (depends on 8)

The preparation method according to claim 8, wherein the weight percentage of the bacteria co-expressing aspartase and L-aspartate-α-decarboxylase to the initial fumaric acid in the reactant is 10%-40% (w/w).

### Claim 10 (depends on 1)

The preparation method according to claim 1, wherein an initial molar ratio of the fumaric acid to the aqueous ammonia in the reactant is 1:2.

### Claim 11 (depends on 1)

The preparation method according to claim 1, wherein the added fumaric acid is added in a fed-batch manner during the reaction.

### Claim 12 (depends on 11)

The preparation method according to claim 11, wherein the concentration of the added fumaric acid is ranged from 50 to 400 g/L, and a fed-batch speed thereof allows a pH value to be controlled at 6.8-7.2 during the reaction.

### Claim 13 (depends on 1)

A method for preparing β-alanine salt, comprising the following steps:
(a) preparing β-alanine by the preparation method according to claim 1; and
(b) reacting the β-alanine obtained in step (a) with an alkaline solution.

### Claim 14 (depends on 13)

The preparation method according to claim 13, wherein the β-alanine salt is an alkali metal or alkaline earth metal salt of β-alanine, and the alkaline solution contains alkali metal or alkaline earth metal cations.

### Claim 15 (depends on 13)

The preparation method according to claim 13, wherein the β-alanine salt is calcium β-alanine, sodium β-alanine, or potassium β-alanine.

### Claim 16 (depends on 1)

A method for preparing pantothenate, comprising the following steps:
(a) preparing β-alanine by the method according to claim 1;
(b) reacting the β-alanine obtained in step (a) with an alkaline solution to prepare β-alanine salt; and
(c) reacting pantolactone or pantoic acid with the β-alanine salt obtained in step (b).

### Claim 17 (depends on 16)

The preparation method according to claim 16, wherein the pantolactone is D-pantolactone, and the pantoic acid is D-pantoic acid.

### Claim 18 (depends on 16)

The preparation method according to claim 16, wherein the pantothenate is calcium pantothenate, sodium pantothenate, or potassium pantothenate.
